Attachment 1 - SOW - Electronic Drug Database.docx

VHA WCHCS

Comprehensive Drug Information Database Statement of Work

1) Introduction/Scope of Work: The contractor shall provide all resources necessary to accomplish the deliverables described in this Statement of Work (SOW), except as may be otherwise specified. The contractor shall provide 24/7/365 online web access to electronic medical references as stated herein for staff at facilities/offices in VHA WCHCS.

2) Place of Performance/Delivery: The database will be used at the VHA Western Colorado Healthcare System located at 2121 North Avenue, Grand Junction, Colorado 81501.

3) Period of Performance: The period of performance shall be a 12-month base period with 4, 12-month option periods. The Contractor shall provide technical support during normal business hours excluding Federal holidays or building closures.

4) General Tasks/Requirements: The U.S. Health Care System has transitioned from hardcopy medical references to electronic reference databases. Staff of about 600 in VHA WCHCS require online web access to searchable medical reference databases for quick and easy retrieval of up to date and evidence based medical information for health care providers and patients. Electronic medical references reduce the need for multiple individual copies of expensive resources. This method provides a more efficient manner of retrieving medically necessary information to meet the clinical mission of serving Veterans within the VHA WCHCS Network.

a) The contractor shall provide 24/7/365 license rights for immediate access to multiple users for any web-enabled computer to employees located within any of the medical facilities or offices of VHA WCHCS.

b) In addition to regular web-based access described above, the electronic reference shall be accessible remotely through Virtual Private Network (VPN), Citrix Access Gateway (CAG) as well as mobile devices such as Smartphone or iPad devices. The drug database shall be compatible with the most current VA operating system, which is currently Microsoft Windows 10 and shall be accessible using VA standard internet browsers, which are currently Microsoft Edge, Microsoft Internet Explorer, and Google Chrome.

c) All information Technology (IT) resources required to provide access to electronic reference shall be documented as approved by VA Technical Reference Module (TRM) webpage: (https://www.oit.va.gov/Services/TRM/TRMHomePage.aspx).

d) The electronic medical subscription should include the following Characteristics:

i) Reference must include access to Trissel’s IV compatibility, pharmaceutical storage and stability information, clinical details about non-FDA approved or off-label indications and investigational therapies to include evidence-based articles.

ii) Articles must include direct links to references.

iii) Tool must include a detailed drug-drug interaction checker to include allergy interaction checker, toxicology database with search function by drug, patient medication/education handouts, dosing based on specific formulations of products (not grouped together), drug identification, administration recommendations, drug dilution instructions, drug pricing reference, pharmacokinetic data, adverse event incidence data.

iv) Reference must include pharmaceutical calculators (to include creatinine clearance).

e) Drug Prescribing Information: Comprehensive information needed to safely prescribe, dispense, and administer US and non-US marketed drugs, including biologic agents, prescription drugs, and over the counter (OTC) drugs, as well as investigational drugs. The prescribing information should be unbiased and fully referenced. The information provided must include both on-label (FDA approved) information as well as off-label information.

The prescribing information provided shall include:

· Drug description and availability

· Generic equivalency ratings

· Clinical Pharmacology and Pharmacokinetics

· Drug Indication and usage

· FDA Approved indications

· Non-FDA Approved indications

· Contraindications

· Warnings

· Precautions

· Dosing for general population

· Dosing for special populations

· Geriatrics

· Pediatrics

· Pregnancy

· Including teratogenic risks and other reproductive risks

· Lactation

· Drug Monitoring

· Adverse Drug Reactions

· Drug interactions

· Drug-Disease

· Drug-Drug

· Drug-Lab test

· Drug-Food

· Drug-Allergy

· Overdosage

· Drug Interaction Checking for user entered drug lists

· Drug Identification – Identify drugs by imprint codes as well as shape, color, and logo designs

· Standard Terminology Mapping

· AHFS mapping

· Healthcare Common Procedure Coding System Codes (HCPCS)

· RxNorm Mapping

· Patient Education Information

· FDA Approved Med Guides

· Patient Medication Information

i) Poisoning Treatment Information

· Ingredient information for pharmaceutical, biological, and commercial products

· Treatment information for toxic exposures

ii) Disease State Information

· Evidence based, referenced information for common diseases, providing information about diagnosis and treatment of common diseases, treatment guidelines, and references.

· Emergency Medicine specific topics must be included

iii) Medication and Chemical Hazard Information

· Material Safety Data Sheets (MSDS) for drugs and chemicals used for compounding

· Treatment Guidelines for workplace toxic exposures

· NIOSH Hazardous Drug Identification

· USP <800> precautions and handling information

iv) Patient Education

· FDA Medication Guides

· Patient Medication Information (PMI) sheets

· Patient medical condition information to include general information, pre-care, inpatient care, and post-discharge care for common diagnoses.

v) IV compatibility

· Information needed to allow appropriate IV compounding by Pharmacy and other staff including solution compatibility, appropriate concentrations, storage conditions, stability, and reconstitution instructions. References must be included.

· Ability for staff to check compatibility of multiple IV medications via Y-Site administration, TPN compatibility, and admixture compatibility

f) All software and content upgrades shall be available at no additional cost to the government during the Period of Performance. Database content shall be updated regularly throughout the performance period, at no less than monthly frequency.

g) Contractor shall provide technical support contact phone numbers and email contacts and shall provide timely technical support during operational hours (8 a.m. through 6 p.m. Eastern Time, weekdays). The contractor is expected to troubleshoot access as needed, but it will not be necessary to respond during non-operational hours.

h) Contractor shall provide on-line training tutorials to users at no additional expense to the government. Contractor shall also provide on-site training, briefings, and updates to Health Care Systems within VHA WCHCS Network if requested at no additional charge to government.

5) Security Consideration: Authorized OIT Personnel will conduct all installation locally and Vendor/Contractor will not be onsite; therefore, no security clearance is necessary for Vendor/Contractor. Troubleshooting after installation will be conducted via telephone or video teleconference.